Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams
暂无分享,去创建一个
Radhe Mohan | Dragan Mirkovic | Wayne D Newhauser | Phillip J Taddei | Yuanshui Zheng | Annelise Giebeler | Jonas D Fontenot | R. Mohan | W. Newhauser | J. Fontenot | David Kornguth | P. Taddei | D. Mirkovic | A. Giebeler | D. Kornguth | Y. Zheng | Yuanshui Zheng | Y. Zheng
[1] Design tools for proton therapy nozzles based on the double-scattering foil technique. , 2005, Radiation protection dosimetry.
[2] Jack Valentin,et al. Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR) , 2003 .
[3] R. Sievert,et al. Book Reviews : Recommendations of the International Commission on Radiological Protection (as amended 1959 and revised 1962). I.C.R.P. Publication 6. 70 pp. PERGAMON PRESS. Oxford, London and New York, 1964. £1 5s. 0d. [TB/54] , 1964 .
[4] Kenneth A. van Riper. A CT and MRI scan to MCNP input conversion program. , 2005 .
[5] Robert J. Schneider,et al. Range modulators for protons and heavy ions , 1975 .
[6] J. Slater,et al. Role for proton beam irradiation in treatment of pediatric CNS malignancies. , 1992, International journal of radiation oncology, biology, physics.
[7] S Agosteo,et al. Secondary neutron and photon dose in proton therapy. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] Torunn I Yock,et al. Physiologic and radiographic evidence of the distal edge of the proton beam in craniospinal irradiation. , 2007, International journal of radiation oncology, biology, physics.
[9] C. Meisner,et al. Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] D. R. White,et al. The composition of body tissues. , 1986, The British journal of radiology.
[11] K. Coombes,et al. Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy , 2008, Physics in medicine and biology.
[12] W. Newhauser,et al. Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit , 2008, Physics in medicine and biology.
[13] S. Woo,et al. Reducing Stray Radiation Dose for a Pediatric Patient Receiving Proton Craniospinal Irradiation , 2008, Nuclear technology.
[14] M. Wagner. Automated range compensation for proton therapy. , 1982, Medical physics.
[15] Anatoly Rosenfeld,et al. Out-of-field dose equivalents delivered by proton therapy of prostate cancer. , 2007, Medical physics.
[16] A. Koehler,et al. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field , 2002 .
[17] P Chauvel,et al. Monte Carlo simulation of a protontherapy platform devoted to ocular melanoma. , 2005, Medical physics.
[18] T. Bortfeld,et al. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume. , 1997, International journal of radiation oncology, biology, physics.
[19] R. Mohan,et al. The risk of developing a second cancer after receiving craniospinal proton irradiation , 2009, Physics in medicine and biology.
[20] E. Pedroni,et al. Secondary neutron dose during proton therapy using spot scanning. , 2002, International journal of radiation oncology, biology, physics.
[21] T. Björk-Eriksson,et al. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study , 2005, Acta oncologica.
[22] T. Pietsch,et al. Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] George Starkschall,et al. Determination of output factors for small proton therapy fields. , 2007, Medical physics.
[24] Uwe Titt,et al. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method. , 2008, Physics in medicine and biology.
[25] D. Brenner,et al. Secondary neutrons in clinical proton radiotherapy: a charged issue. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] Andrew K. Lee,et al. Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer , 2008, Physics in medicine and biology.
[27] Uwe Schneider,et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. , 2002, International journal of radiation oncology, biology, physics.
[28] Uwe Titt,et al. Monte Carlo simulations of a nozzle for the treatment of ocular tumours with high-energy proton beams , 2005, Physics in medicine and biology.
[29] W. Newhauser,et al. Equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy for prostate cancer , 2008, Physics in medicine and biology.
[30] Radhe Mohan,et al. Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants? , 2008, Physics in medicine and biology.
[31] E. Pedroni,et al. The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. , 1995, Medical physics.
[32] M Bues,et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. , 2004, International journal of radiation oncology, biology, physics.
[33] V. Anferov,et al. THE INDIANA UNIVERSITY PROTON THERAPY SYSTEM , 2006 .
[34] E. Hall,et al. Intensity-modulated radiation therapy, protons, and the risk of second cancers. , 2006, International journal of radiation oncology, biology, physics.
[35] U. Titt,et al. Patient neutron dose equivalent exposures outside of the proton therapy treatment field. , 2005, Radiation protection dosimetry.
[36] Radhe Mohan,et al. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm , 2007, Physics in medicine and biology.
[37] D. R. White,et al. Average soft-tissue and bone models for use in radiation dosimetry. , 1987, The British journal of radiology.
[38] J M Slater,et al. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. , 2000, International journal of radiation oncology, biology, physics.
[39] T. Bortfeld,et al. Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions. , 2000, Physics in medicine and biology.
[40] R. Mohan,et al. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy , 2007, Physics in medicine and biology.
[41] R. Mohan,et al. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy , 2007, Physics in medicine and biology.
[42] M. Tadokoro,et al. Measurement of neutron dose distribution for a passive scattering nozzle at the Proton Medical Research Center (PMRC) , 2006 .
[43] J. Herault,et al. Spread-out Bragg peak and monitor units calculation with the Monte Carlo code MCNPX. , 2007, Medical physics.
[44] W. Newhauser,et al. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams , 2005, Physics in medicine and biology.
[45] B. Jereb,et al. Patterns of failure in patients with medulloblastoma , 1982, Cancer.
[46] Alfred R. Smith,et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? , 2005, International journal of radiation oncology, biology, physics.
[47] Brian Wang,et al. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment , 2005, Physics in medicine and biology.
[48] D. Kirsch,et al. New technologies in radiation therapy for pediatric brain tumors: The rationale for proton radiation therapy , 2004, Pediatric blood & cancer.
[49] R. Olsher,et al. WENDI: an improved neutron rem meter. , 2000, Health physics.
[50] J. Habrand,et al. Proton beam therapy in the management of central nervous system tumors in childhood: the preliminary experience of the Centre de Protonthérapie d'Orsay. , 2003, Medical and pediatric oncology.
[51] Bengt Jönsson,et al. Cost‐effectiveness of proton radiation in the treatment of childhood medulloblastoma , 2005, Cancer.
[52] Harald Paganetti,et al. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms , 2008, Physics in medicine and biology.
[53] J. Slater,et al. Reducing Toxicity from Craniospinal Irradiation: Using Proton Beams to Treat Medulloblastoma in Young Children , 2004, Cancer journal.
[54] Jonas D. Fontenot,et al. SU‐FF‐T‐25: A Monte‐Carlo Based Dose Engine for Proton Radiotherapy Treatment Planning , 2007 .
[55] Icrp. Recommendations of the International Commission on Radiological Protection Publication 60 , 1991 .
[56] R. Mohan,et al. Monte Carlo simulations of stray neutron radiation exposures in proton therapy , 2007 .
[57] Richard Wakeford,et al. Uncertainties in Fatal Cancer Risk Estimates Used in Radiation Protection , 1998 .
[58] D. R. White,et al. The composition of body tissues (II). Fetus to young adult. , 1991, The British journal of radiology.
[59] W. Newhauser,et al. Virtual commissioning of a treatment planning system for proton therapy of ocular cancers. , 2005, Radiation protection dosimetry.
[60] Christian Hilbes,et al. The PSI Gantry 2: a second generation proton scanning gantry. , 2004, Zeitschrift fur medizinische Physik.